<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>602</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15182995</PubmedId>
            <Abstract>Interferon-gamma (IFN-gamma) enzyme-linked immunospot (ELISPOT) has become an important tool in studying antigen-specific T lymphocyte responses. Soluble peptides can be used to map T-cell epitopes, providing information that is useful in the design and evaluation of vaccines as well as studies of immunopathogenesis. To date, this assay has not been widely utilized in feline immunodeficiency virus (FIV) research. We have developed a feline IFN-gamma ELISPOT assay and used it to determine FIV-specific T-cell epitopes recognized by infected cats. A panel of 331 peptides, 15 amino acids in length and overlapping by 10 residues was synthesized. The peptide library spanned the FIV structural (Gag), envelope (Env), reverse transcriptase (RT), and open-reading-frame A (OrfA) proteins. Initially, 34 pools, containing 7-10 peptides each were screened by IFN-gamma ELISPOT against peripheral blood mononuclear cells (PBMC) from eight cats chronically infected with the NCSU(1) molecular clone of FIV and four uninfected control cats. Individual peptides from pools recognized by FIV+ cats were then evaluated and optimal peptides were combined into pools representing Gag, Env, RT, and OrfA. A higher percentage of FIV infected cats were identified as responders against the peptide pools when using fresh PBMC as compared to cryopreserved PBMC. In vitro restimulation of cryopreserved PBMC with the peptide pools improved the sensitivity of the assay to similar levels as observed from fresh samples. Individual peptides used in the pools were generally found to stimulate CD8+ T-cells more efficiently than CD4+ T-cells. Comparison of the peptide sequences to representative FIV sequences from clades A-D showed conservation was high among Gag and RT peptides, variable among Env peptides and low for OrfA peptides. The IFN-gamma ELISPOT assay and FIV-specific peptide pools we describe here will be useful in assessing cell-mediated responses to experimental FIV vaccines.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>49-59</ArticlePages>
            <ArticleTitle>Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Dean</LastName>
                    <ForeName>Gregg A</ForeName>
                </Author>
                <Author>
                    <LastName>LaVoy</LastName>
                    <ForeName>Alora</ForeName>
                </Author>
                <Author>
                    <LastName>Burkhard</LastName>
                    <ForeName>Mary Jo</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, 4700 Hillsborough Street, Raleigh, NC 27606, USA. gregg_dean@ncsu.edu</Affiliations>
            <ArticleChemicalList>Antibodies, Monoclonal;Gene Products, env;Gene Products, gag;Peptide Fragments;Peptide Library;RNA, Messenger;Interferon-gamma;RNA-Directed DNA Polymerase</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Animals; Antibodies, Monoclonal(immunology); Antibody Specificity(immunology); Cats; Feline Acquired Immunodeficiency Syndrome(immunology; virology); Gene Products, env(immunology); Gene Products, gag(immunology); Immunodeficiency Virus, Feline(immunology); Immunoenzyme Techniques(methods; veterinary); Interferon-gamma(genetics; immunology); Molecular Sequence Data; Peptide Fragments(immunology); Peptide Library; Peptide Mapping; RNA, Messenger(chemistry; genetics); RNA-Directed DNA Polymerase(immunology); Reverse Transcriptase Polymerase Chain Reaction(veterinary)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>100</Volume>
                <Issue>1-2</Issue>
                <Title>Veterinary immunology and immunopathology</Title>
                <Issn>0165-2427</Issn>
                <MedlineTa>Vet Immunol Immunopathol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>GagMA 81â€“95</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>DMAIVTLKVFAVVGL</LinearSequence>
                        <StartingPosition>81</StartingPosition>
                        <EndingPosition>95</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAP51393.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11673</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>9351</EpitopeId>
                <ReferenceStartingPosition>81</ReferenceStartingPosition>
                <ReferenceEndingPosition>95</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The cats in this study were infected with the FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8906</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DMAIVTLKVFAVVGL</LinearSequence>
                                        <StartingPosition>81</StartingPosition>
                                        <EndingPosition>95</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAP51393.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each.  Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>5556</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DMAIVTLKVFAVVGL</LinearSequence>
                                        <StartingPosition>81</StartingPosition>
                                        <EndingPosition>95</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAP51393.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>229.0</QuantitativeMeasurement>
                            <NumberOfSubjectsTested>8</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>12.5</ResponseFrequency>
                            <AssayComments>This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted. Reactivity to this epitope was completely abrogated in the CD8+ depleted cultures, indicating this epitope is CD8+ restricted.The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools.  The other 7 subjects were not evaluated.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>GagMA 91â€“105</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>AVVGLLNMTVSTAAA</LinearSequence>
                        <StartingPosition>91</StartingPosition>
                        <EndingPosition>105</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>Q05313.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11673</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>5599</EpitopeId>
                <ReferenceStartingPosition>91</ReferenceStartingPosition>
                <ReferenceEndingPosition>105</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The cats in this study were infected with the FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8907</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AVVGLLNMTVSTAAA</LinearSequence>
                                        <StartingPosition>91</StartingPosition>
                                        <EndingPosition>105</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>Q05313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>5557</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AVVGLLNMTVSTAAA</LinearSequence>
                                        <StartingPosition>91</StartingPosition>
                                        <EndingPosition>105</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>Q05313.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>38.0</QuantitativeMeasurement>
                            <NumberOfSubjectsTested>8</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>12.5</ResponseFrequency>
                            <AssayComments>This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted. Reactivity to this epitope was completely abrogated in the CD8+ depleted cultures, indicating this epitope is CD8+ restricted.The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools.  The other 7 subjects were not evaluated.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>GagCA 203â€“217</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LDEELKQLTAEYDRT</LinearSequence>
                        <SourceMolecule>
                            <IedbAccession>SRC280147</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>11673</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>35133</EpitopeId>
                <ReferenceStartingPosition>203</ReferenceStartingPosition>
                <ReferenceEndingPosition>217</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Internal Identifier-no external match available</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The cats in this study were infected with the FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8908</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LDEELKQLTAEYDRT</LinearSequence>
                                        <SourceMolecule>
                                            <IedbAccession>SRC280147</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>5558</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LDEELKQLTAEYDRT</LinearSequence>
                                        <SourceMolecule>
                                            <IedbAccession>SRC280147</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>98.0</QuantitativeMeasurement>
                            <NumberOfSubjectsTested>8</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>12.5</ResponseFrequency>
                            <AssayComments>This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted. Reactivity to this epitope was completely abrogated in the CD8+ depleted cultures, indicating this epitope is CD8+ restricted.The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools.  The other 7 subjects were not evaluated.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>GagCA 213â€“227</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>EYDRTHPPDGPRPLP</LinearSequence>
                        <StartingPosition>213</StartingPosition>
                        <EndingPosition>227</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P31821.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11673</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>14988</EpitopeId>
                <ReferenceStartingPosition>213</ReferenceStartingPosition>
                <ReferenceEndingPosition>227</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The cats in this study were infected with the FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8909</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EYDRTHPPDGPRPLP</LinearSequence>
                                        <StartingPosition>213</StartingPosition>
                                        <EndingPosition>227</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P31821.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>5559</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EYDRTHPPDGPRPLP</LinearSequence>
                                        <StartingPosition>213</StartingPosition>
                                        <EndingPosition>227</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P31821.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>51.0</QuantitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted. Reactivity to this epitope was completely abrogated in the CD8+ depleted cultures, indicating this epitope is CD8+ restricted. The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools.  The other 7 subjects were not evaluated.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>GagCA 233â€“247</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>EIMGIGLTQEQQAEA</LinearSequence>
                        <StartingPosition>233</StartingPosition>
                        <EndingPosition>247</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P16087.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11673</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>12522</EpitopeId>
                <ReferenceStartingPosition>233</ReferenceStartingPosition>
                <ReferenceEndingPosition>247</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The cats in this study were infected with the FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>5560</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EIMGIGLTQEQQAEA</LinearSequence>
                                        <StartingPosition>233</StartingPosition>
                                        <EndingPosition>247</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P16087.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>44.0</QuantitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted. Reactivity to this epitope was completely abrogated in the CD8+ depleted cultures, indicating this epitope is CD8+ restricted. The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools.  The other 7 subjects were not evaluated.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8910</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EIMGIGLTQEQQAEA</LinearSequence>
                                        <StartingPosition>233</StartingPosition>
                                        <EndingPosition>247</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P16087.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>GagCA 263â€“277</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ALGKLAAIKAKSPRA</LinearSequence>
                        <StartingPosition>263</StartingPosition>
                        <EndingPosition>277</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P16087.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11673</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>2562</EpitopeId>
                <ReferenceStartingPosition>263</ReferenceStartingPosition>
                <ReferenceEndingPosition>277</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The cats in this study were infected with the FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8911</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ALGKLAAIKAKSPRA</LinearSequence>
                                        <StartingPosition>263</StartingPosition>
                                        <EndingPosition>277</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P16087.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>5561</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ALGKLAAIKAKSPRA</LinearSequence>
                                        <StartingPosition>263</StartingPosition>
                                        <EndingPosition>277</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P16087.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted. Reactivity to this epitope was significantly reduced in the CD8+ depleted cultures, indicating this epitope is predominantly recognized by CD8+ cell, although some CD4+ activity was detected. The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools.  The other 7 subjects were not evaluated.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>GagCA 283â€“297</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GAKEDYSSFIDRLFA</LinearSequence>
                        <StartingPosition>283</StartingPosition>
                        <EndingPosition>297</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P16087.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11673</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>18636</EpitopeId>
                <ReferenceStartingPosition>283</ReferenceStartingPosition>
                <ReferenceEndingPosition>297</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The cats in this study were infected with the FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8912</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GAKEDYSSFIDRLFA</LinearSequence>
                                        <StartingPosition>283</StartingPosition>
                                        <EndingPosition>297</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P16087.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each.  Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>5562</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GAKEDYSSFIDRLFA</LinearSequence>
                                        <StartingPosition>283</StartingPosition>
                                        <EndingPosition>297</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P16087.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted.  Reactivity to this epitope was significantly reduced in the CD8+ depleted cultures, indicating this epitope is predominantly recognized by CD8+ cell, although some CD4+ activity was detected. The cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools. The other 7 subjects were not evaluated.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>GagCA 293â€“307</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>DRLFAQIDQEQNTAE</LinearSequence>
                        <StartingPosition>293</StartingPosition>
                        <EndingPosition>307</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P16087.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11673</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>10002</EpitopeId>
                <ReferenceStartingPosition>293</ReferenceStartingPosition>
                <ReferenceEndingPosition>307</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The cats in this study were infected with the FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8913</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DRLFAQIDQEQNTAE</LinearSequence>
                                        <StartingPosition>293</StartingPosition>
                                        <EndingPosition>307</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P16087.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>5565</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DRLFAQIDQEQNTAE</LinearSequence>
                                        <StartingPosition>293</StartingPosition>
                                        <EndingPosition>307</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P16087.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted. Reactivity to this epitope was significantly reduced in the CD8+ depleted cultures, indicating this epitope is predominantly recognized by CD8+ cell, although some CD4+ activity was detected.The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools.  The other 7 subjects were not evaluated.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>GagCA 298â€“312</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>QIDQEQNTAEVKLYL</LinearSequence>
                        <StartingPosition>298</StartingPosition>
                        <EndingPosition>312</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P16087.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11673</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>51048</EpitopeId>
                <ReferenceStartingPosition>298</ReferenceStartingPosition>
                <ReferenceEndingPosition>312</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The cats in this study were infected with the FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8914</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QIDQEQNTAEVKLYL</LinearSequence>
                                        <StartingPosition>298</StartingPosition>
                                        <EndingPosition>312</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P16087.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>5569</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QIDQEQNTAEVKLYL</LinearSequence>
                                        <StartingPosition>298</StartingPosition>
                                        <EndingPosition>312</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P16087.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted.  Reactivity to this epitope was significantly reduced in the CD8+ depleted cultures, indicating this epitope is predominantly recognized by CD8+ cell, although some CD4+ activity was detected. The cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools. The other 7 subjects were not evaluated.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>EnvSU 156â€“170</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GPNQTCMWNTSQIQD</LinearSequence>
                        <StartingPosition>156</StartingPosition>
                        <EndingPosition>170</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P87682</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11673</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>21718</EpitopeId>
                <ReferenceStartingPosition>156</ReferenceStartingPosition>
                <ReferenceEndingPosition>170</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The cats in this study were infected with the FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8915</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GPNQTCMWNTSQIQD</LinearSequence>
                                        <StartingPosition>156</StartingPosition>
                                        <EndingPosition>170</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P87682</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each.  Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>5570</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GPNQTCMWNTSQIQD</LinearSequence>
                                        <StartingPosition>156</StartingPosition>
                                        <EndingPosition>170</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P87682</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted.  Reactivity to this epitope was significantly reduced in the CD8+ depleted cultures, indicating this epitope is predominantly recognized by CD8+ cell, although some CD4+ activity was detected. The cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools. The other 7 subjects were not evaluated.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>EnvSU 181â€“196</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>QRAYYKNCKWEKTDV</LinearSequence>
                        <StartingPosition>2</StartingPosition>
                        <EndingPosition>16</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAQ11407.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11673</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>52190</EpitopeId>
                <ReferenceStartingPosition>181</ReferenceStartingPosition>
                <ReferenceEndingPosition>196</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The cats in this study were infected with the FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8916</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QRAYYKNCKWEKTDV</LinearSequence>
                                        <StartingPosition>2</StartingPosition>
                                        <EndingPosition>16</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAQ11407.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each.  Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>5571</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QRAYYKNCKWEKTDV</LinearSequence>
                                        <StartingPosition>2</StartingPosition>
                                        <EndingPosition>16</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAQ11407.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>84.0</QuantitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted.  Reactivity to this epitope was significantly reduced in the CD8+ depleted cultures, indicating this epitope is predominantly recognized by CD8+ cell, although some CD4+ activity was detected. The cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools. The other 7 subjects were not evaluated.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>EnvSU 261â€“275</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>AWIEFGCHRNKSKLH</LinearSequence>
                        <StartingPosition>439</StartingPosition>
                        <EndingPosition>453</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>Q04993.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11673</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>5665</EpitopeId>
                <ReferenceStartingPosition>261</ReferenceStartingPosition>
                <ReferenceEndingPosition>275</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The cats in this study were infected with the FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>5572</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AWIEFGCHRNKSKLH</LinearSequence>
                                        <StartingPosition>439</StartingPosition>
                                        <EndingPosition>453</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>Q04993.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>28.0</QuantitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted.  Reactivity to this epitope was significantly reduced in the CD8+ depleted cultures, indicating this epitope is predominantly recognized by CD8+ cell, although some CD4+ activity was detected. The cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools. The other 7 subjects were not evaluated.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8917</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AWIEFGCHRNKSKLH</LinearSequence>
                                        <StartingPosition>439</StartingPosition>
                                        <EndingPosition>453</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>Q04993.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>EnvSU 296â€“110</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>DTCGNTQNVSGANPV</LinearSequence>
                        <StartingPosition>108</StartingPosition>
                        <EndingPosition>122</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>ABO27589.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11673</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>10301</EpitopeId>
                <ReferenceStartingPosition>296</ReferenceStartingPosition>
                <ReferenceEndingPosition>310</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The cats in this study were infected with the FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>5573</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DTCGNTQNVSGANPV</LinearSequence>
                                        <StartingPosition>108</StartingPosition>
                                        <EndingPosition>122</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>ABO27589.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>74.0</QuantitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted. Reactivity to this epitope was completely abrogated in the CD8+ depleted cultures, indicating this epitope is CD8+ restricted.The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools.  The other 7 subjects were not evaluated.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8918</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DTCGNTQNVSGANPV</LinearSequence>
                                        <StartingPosition>108</StartingPosition>
                                        <EndingPosition>122</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>ABO27589.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each.  Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>EnvSU 381â€“395</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MACPNNQGILRNWYN</LinearSequence>
                        <SourceMolecule>
                            <IedbAccession>SRC26410</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>11673</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>41013</EpitopeId>
                <ReferenceStartingPosition>381</ReferenceStartingPosition>
                <ReferenceEndingPosition>395</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Internal Identifier-no external match available</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The cats in this study were infected with the FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>5574</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MACPNNQGILRNWYN</LinearSequence>
                                        <SourceMolecule>
                                            <IedbAccession>SRC26410</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted. Reactivity to this epitope occurred in cultures depleted of either CD4+ or CD8+, suggesting these epitopes are recognized by both T-cell subsets. The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools.  The other 7 subjects were not evaluated.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8919</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MACPNNQGILRNWYN</LinearSequence>
                                        <SourceMolecule>
                                            <IedbAccession>SRC26410</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each.  Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>EnvSU 391â€“405</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>RNWYNPVAGLRQSLE</LinearSequence>
                        <StartingPosition>570</StartingPosition>
                        <EndingPosition>584</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>Q04993.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11673</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>55093</EpitopeId>
                <ReferenceStartingPosition>391</ReferenceStartingPosition>
                <ReferenceEndingPosition>405</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The cats in this study were infected with the FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>5575</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RNWYNPVAGLRQSLE</LinearSequence>
                                        <StartingPosition>570</StartingPosition>
                                        <EndingPosition>584</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>Q04993.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>98.0</QuantitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted. Reactivity to this epitope was completely abrogated in the CD8+ depleted cultures, indicating this epitope is CD8+ restricted.The cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools. The other 7 subjects were not evaluated.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8920</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RNWYNPVAGLRQSLE</LinearSequence>
                                        <StartingPosition>570</StartingPosition>
                                        <EndingPosition>584</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>Q04993.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each.  Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>EnvTM 461â€“475</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>QYHQVLATHQEAIEK</LinearSequence>
                        <StartingPosition>641</StartingPosition>
                        <EndingPosition>655</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P16090.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11673</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>52914</EpitopeId>
                <ReferenceStartingPosition>461</ReferenceStartingPosition>
                <ReferenceEndingPosition>475</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The cats in this study were infected with the FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8921</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QYHQVLATHQEAIEK</LinearSequence>
                                        <StartingPosition>641</StartingPosition>
                                        <EndingPosition>655</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P16090.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>5576</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QYHQVLATHQEAIEK</LinearSequence>
                                        <StartingPosition>641</StartingPosition>
                                        <EndingPosition>655</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P16090.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted. Reactivity to this epitope was significantly reduced in the CD8+ depleted cultures, indicating this epitope is predominantly recognized by CD8+ cell, although some CD4+ activity was detected.The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools. The other 7 subjects were not evaluated.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>EnvTM 581â€“596</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KKGIQQLQKWEDWVG</LinearSequence>
                        <StartingPosition>761</StartingPosition>
                        <EndingPosition>775</EndingPosition>
                        <SourceMolecule>
                            <IedbAccession>SRC26410</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>11673</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>31548</EpitopeId>
                <ReferenceStartingPosition>581</ReferenceStartingPosition>
                <ReferenceEndingPosition>596</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The cats in this study were infected with the FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>5577</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KKGIQQLQKWEDWVG</LinearSequence>
                                        <StartingPosition>761</StartingPosition>
                                        <EndingPosition>775</EndingPosition>
                                        <SourceMolecule>
                                            <IedbAccession>SRC26410</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted.  Reactivity to this epitope was significantly reduced in the CD8+ depleted cultures, indicating this epitope is predominantly recognized by CD8+ cell, although some CD4+ activity was detected. The cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools. The other 7 subjects were not evaluated.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8922</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KKGIQQLQKWEDWVG</LinearSequence>
                                        <StartingPosition>761</StartingPosition>
                                        <EndingPosition>775</EndingPosition>
                                        <SourceMolecule>
                                            <IedbAccession>SRC26410</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>EnvTM 591â€“605</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>EDWVGWIGNIPQYLK</LinearSequence>
                        <StartingPosition>593</StartingPosition>
                        <EndingPosition>607</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P87682</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11673</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>11475</EpitopeId>
                <ReferenceStartingPosition>591</ReferenceStartingPosition>
                <ReferenceEndingPosition>605</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The cats in this study were infected with the FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>5578</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EDWVGWIGNIPQYLK</LinearSequence>
                                        <StartingPosition>593</StartingPosition>
                                        <EndingPosition>607</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P87682</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted.The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools.  The other 7 subjects were not evaluated.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8923</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EDWVGWIGNIPQYLK</LinearSequence>
                                        <StartingPosition>593</StartingPosition>
                                        <EndingPosition>607</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P87682</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>RT 151â€“165</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GWVLSPLIYQSTLDN</LinearSequence>
                        <StartingPosition>311</StartingPosition>
                        <EndingPosition>325</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>ABO69453.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11673</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>23297</EpitopeId>
                <ReferenceStartingPosition>151</ReferenceStartingPosition>
                <ReferenceEndingPosition>165</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The cats in this study were infected with the FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8924</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GWVLSPLIYQSTLDN</LinearSequence>
                                        <StartingPosition>311</StartingPosition>
                                        <EndingPosition>325</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>ABO69453.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each.  Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>5579</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GWVLSPLIYQSTLDN</LinearSequence>
                                        <StartingPosition>311</StartingPosition>
                                        <EndingPosition>325</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>ABO69453.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>61.0</QuantitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted. Reactivity to this epitope was completely abrogated in the CD8+ depleted cultures, indicating this epitope is CD8+ restricted. The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools.  The other 7 subjects were not evaluated.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>RT 156â€“170</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>PLIYQSTLDNIIQPF</LinearSequence>
                        <StartingPosition>312</StartingPosition>
                        <EndingPosition>326</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P19028.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11673</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>48374</EpitopeId>
                <ReferenceStartingPosition>156</ReferenceStartingPosition>
                <ReferenceEndingPosition>170</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The cats in this study were infected with the FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>5580</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>PLIYQSTLDNIIQPF</LinearSequence>
                                        <StartingPosition>312</StartingPosition>
                                        <EndingPosition>326</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P19028.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>RT 161â€“175</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>STLDNIIQPFIRQNP</LinearSequence>
                        <StartingPosition>317</StartingPosition>
                        <EndingPosition>331</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P19028.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11673</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>61712</EpitopeId>
                <ReferenceStartingPosition>161</ReferenceStartingPosition>
                <ReferenceEndingPosition>175</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The cats in this study were infected with the FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>5581</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>STLDNIIQPFIRQNP</LinearSequence>
                                        <StartingPosition>317</StartingPosition>
                                        <EndingPosition>331</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P19028.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>31.0</QuantitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted.  Reactivity to this epitope was completely abrogated in the CD8+ depleted cultures, indicating this epitope is CD8+ restricted. The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools.  The other 7 subjects were not evaluated.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8925</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>STLDNIIQPFIRQNP</LinearSequence>
                                        <StartingPosition>317</StartingPosition>
                                        <EndingPosition>331</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P19028.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>RT 166â€“180</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IIQPFIRQNPELDIY</LinearSequence>
                        <SourceMolecule>
                            <IedbAccession>SRC276215</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>11673</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>26646</EpitopeId>
                <ReferenceStartingPosition>166</ReferenceStartingPosition>
                <ReferenceEndingPosition>180</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Internal Identifier-no external match available</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The cats in this study were infected with the FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>5582</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IIQPFIRQNPELDIY</LinearSequence>
                                        <SourceMolecule>
                                            <IedbAccession>SRC276215</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>74.0</QuantitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted. Reactivity to this epitope was completely abrogated in the CD8+ depleted cultures, indicating this epitope is CD8+ restricted.The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools.  The other 7 subjects were not evaluated.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8926</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IIQPFIRQNPELDIY</LinearSequence>
                                        <SourceMolecule>
                                            <IedbAccession>SRC276215</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>RT 176â€“190</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ELDIYQYMDDIYIGS</LinearSequence>
                        <StartingPosition>331</StartingPosition>
                        <EndingPosition>345</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P31822.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11673</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>12984</EpitopeId>
                <ReferenceStartingPosition>176</ReferenceStartingPosition>
                <ReferenceEndingPosition>190</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The cats in this study were infected with the FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8927</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ELDIYQYMDDIYIGS</LinearSequence>
                                        <StartingPosition>331</StartingPosition>
                                        <EndingPosition>345</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P31822.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>5583</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ELDIYQYMDDIYIGS</LinearSequence>
                                        <StartingPosition>331</StartingPosition>
                                        <EndingPosition>345</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P31822.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>14.0</QuantitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted. Reactivity to this epitope was completely abrogated in the CD8+ depleted cultures, indicating this epitope is CD8+ restricted. The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools.  The other 7 subjects were not evaluated.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>RT 186â€“200</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IYIGSNLSKKEHKEK</LinearSequence>
                        <StartingPosition>342</StartingPosition>
                        <EndingPosition>356</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P19028.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11673</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>29594</EpitopeId>
                <ReferenceStartingPosition>186</ReferenceStartingPosition>
                <ReferenceEndingPosition>200</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The cats in this study were infected with the FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>5584</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IYIGSNLSKKEHKEK</LinearSequence>
                                        <StartingPosition>342</StartingPosition>
                                        <EndingPosition>356</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P19028.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted. Reactivity to this epitope was significantly reduced in the CD8+ depleted cultures, indicating this epitope is predominantly recognized by CD8+ cell, although some CD4+ activity was detected.The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools. The other 7 subjects were not evaluated.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8928</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IYIGSNLSKKEHKEK</LinearSequence>
                                        <StartingPosition>342</StartingPosition>
                                        <EndingPosition>356</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P19028.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>RT 246â€“260</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>EIPERPTLNELQKLA</LinearSequence>
                        <StartingPosition>401</StartingPosition>
                        <EndingPosition>415</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P31822.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11673</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>12544</EpitopeId>
                <ReferenceStartingPosition>246</ReferenceStartingPosition>
                <ReferenceEndingPosition>260</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The cats in this study were infected with the FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8929</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EIPERPTLNELQKLA</LinearSequence>
                                        <StartingPosition>401</StartingPosition>
                                        <EndingPosition>415</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P31822.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>5585</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EIPERPTLNELQKLA</LinearSequence>
                                        <StartingPosition>401</StartingPosition>
                                        <EndingPosition>415</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P31822.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>18.0</QuantitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted.  Reactivity to this epitope was completely abrogated in the CD8+ depleted cultures, indicating this epitope is CD8+ restricted.The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools. The other 7 subjects were not evaluated.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>OrfA 6â€“20</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TLFNKVTKKLEKEKA</LinearSequence>
                        <SourceMolecule>
                            <IedbAccession>SRC26383</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>11673</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>64797</EpitopeId>
                <ReferenceStartingPosition>6</ReferenceStartingPosition>
                <ReferenceEndingPosition>20</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Internal Identifier-no external match available</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The cats in this study were infected with the FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>8930</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TLFNKVTKKLEKEKA</LinearSequence>
                                        <SourceMolecule>
                                            <IedbAccession>SRC26383</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools. The other 7 subjects were not evaluated..  This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted.  Reactivity to this epitope was completely abrogated in the CD8+ depleted cultures, indicating this epitope is CD8+ restricted.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>5586</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TLFNKVTKKLEKEKA</LinearSequence>
                                        <SourceMolecule>
                                            <IedbAccession>SRC26383</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>OrfA 11â€“25</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>VTKKLEKEKAIRIFV</LinearSequence>
                        <SourceMolecule>
                            <IedbAccession>SRC26383</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>11673</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>71388</EpitopeId>
                <ReferenceStartingPosition>11</ReferenceStartingPosition>
                <ReferenceEndingPosition>25</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Internal Identifier-no external match available</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The cats in this study were infected with the FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>5587</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>VTKKLEKEKAIRIFV</LinearSequence>
                                        <SourceMolecule>
                                            <IedbAccession>SRC26383</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted. The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools.  The other 7 subjects were not evaluated.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8931</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>VTKKLEKEKAIRIFV</LinearSequence>
                                        <SourceMolecule>
                                            <IedbAccession>SRC26383</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>OrfA 64â€“78</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>FYYWQLQSTLSITTA</LinearSequence>
                        <StartingPosition>64</StartingPosition>
                        <EndingPosition>78</EndingPosition>
                        <SourceMolecule>
                            <IedbAccession>SRC26383</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>11673</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 4</LocationOfData>
                <EpitopeId>18492</EpitopeId>
                <ReferenceStartingPosition>64</ReferenceStartingPosition>
                <ReferenceEndingPosition>78</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The cats in this study were infected with the FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8932</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>FYYWQLQSTLSITTA</LinearSequence>
                                        <StartingPosition>64</StartingPosition>
                                        <EndingPosition>78</EndingPosition>
                                        <SourceMolecule>
                                            <IedbAccession>SRC26383</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>5588</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9685</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11673</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>FIV molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU&lt;sub&gt;1&lt;/sub&gt; for 1-2 years.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>FYYWQLQSTLSITTA</LinearSequence>
                                        <StartingPosition>64</StartingPosition>
                                        <EndingPosition>78</EndingPosition>
                                        <SourceMolecule>
                                            <IedbAccession>SRC26383</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>11673</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted. Reactivity to this epitope was completely abrogated in the CD8+ depleted cultures, indicating this epitope is CD8+ restricted.The cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools. The other 7 subjects were not evaluated.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

